367 related articles for article (PubMed ID: 18395683)
1. Sex steroids and vascular responses in hypertension and aging.
Qiao X; McConnell KR; Khalil RA
Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
[TBL] [Abstract][Full Text] [Related]
2. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
4. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
Ross RL; Serock MR; Khalil RA
Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of estrogenic menopausal hormone therapy.
Reslan OM; Khalil RA
Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
[TBL] [Abstract][Full Text] [Related]
6. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.
do Nascimento GR; Barros YV; Wells AK; Khalil RA
Curr Hypertens Rev; 2009 Nov; 5(4):283-306. PubMed ID: 20694192
[TBL] [Abstract][Full Text] [Related]
7. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
Serock MR; Wells AK; Khalil RA
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
[TBL] [Abstract][Full Text] [Related]
8. Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease.
Khalil RA
Future Cardiol; 2007 May; 3(3):283-300. PubMed ID: 19804220
[TBL] [Abstract][Full Text] [Related]
9. Age-related reduction in estrogen receptor-mediated mechanisms of vascular relaxation in female spontaneously hypertensive rats.
Wynne FL; Payne JA; Cain AE; Reckelhoff JF; Khalil RA
Hypertension; 2004 Feb; 43(2):405-12. PubMed ID: 14699001
[TBL] [Abstract][Full Text] [Related]
10. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
Masood DE; Roach EC; Beauregard KG; Khalil RA
Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
[TBL] [Abstract][Full Text] [Related]
11. Sex hormones as potential modulators of vascular function in hypertension.
Khalil RA
Hypertension; 2005 Aug; 46(2):249-54. PubMed ID: 15983238
[TBL] [Abstract][Full Text] [Related]
12. Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.
Khalil RA
Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):29-46. PubMed ID: 20210774
[TBL] [Abstract][Full Text] [Related]
13. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.
Smiley DA; Khalil RA
Curr Med Chem; 2009; 16(15):1863-87. PubMed ID: 19442151
[TBL] [Abstract][Full Text] [Related]
14. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
15. Gender, sex hormones, and vascular tone.
Orshal JM; Khalil RA
Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R233-49. PubMed ID: 14707008
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.
Mazzuca MQ; Mata KM; Li W; Rangan SS; Khalil RA
J Pharmacol Exp Ther; 2015 Feb; 352(2):291-304. PubMed ID: 25472954
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the regulation of vascular tone.
Thompson J; Khalil RA
Clin Exp Pharmacol Physiol; 2003; 30(1-2):1-15. PubMed ID: 12542447
[TBL] [Abstract][Full Text] [Related]
18. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
Sowers MR; Randolph J; Jannausch M; Lasley B; Jackson E; McConnell D
Arch Intern Med; 2008 Oct; 168(19):2146-53. PubMed ID: 18955645
[TBL] [Abstract][Full Text] [Related]
19. Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: potential role of estrogen receptor polymorphisms.
Bechlioulis A; Naka KK; Kalantaridou SN; Chatzikyriakidou A; Papanikolaou O; Kaponis A; Vakalis K; Vezyraki P; Gartzonika K; Mavridis A; Georgiou I; Michalis LK
Maturitas; 2012 Apr; 71(4):389-95. PubMed ID: 22277987
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of estrogen effects on the endothelium: an overview.
Chakrabarti S; Morton JS; Davidge ST
Can J Cardiol; 2014 Jul; 30(7):705-12. PubMed ID: 24252499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
